Diffuse Large B-Cell Lymphoma (DLBCL) presents a high clinical and biological heterogeneity, and the tumor microenvironment chracteristics are important in its progression. The aim of this study was to evaluate tumor T, B cells, macrophages and mast cells distribution in GBC and ABC DLBCL subgroups through a set of morphometric parameters allowing to provide a quantitative evaluation of the morphological features of the spatial patterns generated by these inflammatory cells. Histological ABC and GCB samples were immunostained for CD4, CD8, CD68, CD 163, and tryptase in order to determine both percentage and position of positive cells in the tissue characterizing their spatial distribution. The results evidenced that cell patterns gener...
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma subtype. In Sweden 450 new cases...
Aims. Diffuse large B-cell lymphomas (DLBCL) can be divided into different subgroups (germinal cente...
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with ge...
Diffuse Large B-Cell Lymphoma (DLBCL) presents a high clinical and biological heterogeneity, and the...
Purpose: Tumor-infiltrating immune cells have prognostic sig-nificance and are attractive therapeuti...
While tumor infiltration by CD8+ T cells is now widely accepted to predict outcomes, the clinical si...
Constitutively activated STAT3 is correlated with more advanced clinical stage and overall poor surv...
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL), accounting for ...
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common non-Hodgkin lymphoma subtype....
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL), accounting for ...
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common form of non-Hodgkin lymphoma ...
Diffuse large B cell lymphoma (DLBCL), known as the most common non-Hodgkin lymphoma (NHL) subtype, ...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is recognized a...
Introduction: Immune cells play a prominent role in keeping tumors suppressed, but how the distribut...
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma subtype. In Sweden 450 new cases...
Aims. Diffuse large B-cell lymphomas (DLBCL) can be divided into different subgroups (germinal cente...
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with ge...
Diffuse Large B-Cell Lymphoma (DLBCL) presents a high clinical and biological heterogeneity, and the...
Purpose: Tumor-infiltrating immune cells have prognostic sig-nificance and are attractive therapeuti...
While tumor infiltration by CD8+ T cells is now widely accepted to predict outcomes, the clinical si...
Constitutively activated STAT3 is correlated with more advanced clinical stage and overall poor surv...
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL), accounting for ...
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common non-Hodgkin lymphoma subtype....
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL), accounting for ...
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common form of non-Hodgkin lymphoma ...
Diffuse large B cell lymphoma (DLBCL), known as the most common non-Hodgkin lymphoma (NHL) subtype, ...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is recognized a...
Introduction: Immune cells play a prominent role in keeping tumors suppressed, but how the distribut...
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoma subtype. In Sweden 450 new cases...
Aims. Diffuse large B-cell lymphomas (DLBCL) can be divided into different subgroups (germinal cente...
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with ge...